Pfizer Stock Is Trading Higher Tuesday: What's Going On?
I'm PortAI, I can summarize articles.
Pfizer Inc (PFE) shares rose on Tuesday due to several developments. FDA advisors are set to discuss recommending COVID-19 vaccines for 2025-26 targeting the LP.8.1 strain, which is rapidly spreading. Additionally, Pfizer announced a licensing agreement with 3SBio for SSGJ-707, a bispecific antibody for cancer treatment, involving an upfront payment of $1.25 billion and potential milestone payments of up to $4.8 billion. Pfizer shares were up 1.50% at $23.35, despite being down 12% year-to-date.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments